Publicaciones en colaboración con investigadores/as de Massachusetts General Hospital (10)

2016

  1. Molecular genetic heterogeneity in undifferentiated endometrial carcinomas

    Modern Pathology, Vol. 29, Núm. 11, pp. 1390-1398

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

2013

  1. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

    Human Pathology, Vol. 44, Núm. 2, pp. 244-254

  2. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma

    Modern Pathology, Vol. 26, Núm. 11, pp. 1514-1524

2012

  1. Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: Role for proteins involved in resistance to apoptosis and hypoxia

    Histopathology, Vol. 60, Núm. 3, pp. 460-471

2011

  1. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

    Journal of Pathology, Vol. 223, Núm. 1, pp. 72-80

2009

  1. Pathogenetic pathways in ovarian endometrioid adenocarcinoma: A molecular study of 29 cases

    American Journal of Surgical Pathology, Vol. 33, Núm. 8, pp. 1157-1163

2008

  1. Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen

    Modern Pathology, Vol. 21, Núm. 8, pp. 925-936

2006

  1. High frequency of β-catenin mutations in borderline endometrioid tumours of the ovary

    Journal of Pathology, Vol. 208, Núm. 5, pp. 708-713

2005

  1. Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous Morules)

    American Journal of Surgical Pathology, Vol. 29, Núm. 10, pp. 1322-1329